In previous studies, Apo‐CIII and Apo‐E have been associated with a higher risk of diabetes46; their blood levels were increased in chronic heart disease (CHD) in relation to dyslipoproteinaemia47 and they were elevated in CAD.48 Here, APOC3 is linked to coronary artery disorder.